Note 6 - Shareholders' Equity

12 Months Ended

Mar. 01, 2020

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

6

.     S

HARE

HOLDERS’ EQUITY

Treasury Stock

– On

January 8, 2015,

the Company announced that its Board of Directors had authorized the Company’s purchase, on the open market and in privately negotiated transactions, of up to

1,250,000

shares of its common stock, representing approximately

6%

of the Company’s

20,945,634

total outstanding shares as of the close of business on

January 7, 2015.

This authorization superseded all prior Board of Directors’ authorizations to purchase shares of the Company’s common stock.

On

March 10, 2016,

the Company announced that its Board of Directors authorized the Company’s purchase, on the open market and in privately negotiated transactions, of up to

1,000,000

additional shares of its common stock, in addition to the unused prior authorization to purchase shares of the Company’s common stock announced on

January 8, 2015.

During the

2016

fiscal year, the Company purchased

599,832

shares pursuant to the above authorizations at an aggregate purchase price of

$12,187.

As a result, the Company is authorized to purchase up to a total of

1,531,412

shares of its common stock, representing approximately

7.5%

of the Company’s

20,518,823

total outstanding shares as of the close of business on

March 1, 2020.

Reserved Common Shares

– At

March 1, 2020,

692,100

shares of common stock were reserved for issuance upon exercise of stock options.

Accumulated Other Comprehensive

Earnings (Loss)

– Accumulated balances related to each component of other comprehensive earnings were as follows:

	March 1, 2020		March 3, 2019
Unrealized gains (losses) on investments, net of taxes of $690 and $1,157, respectively	$	668	$	(22	)
Accumulated balance	$	668	$	(22	)